Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Mar 29, 2023 10:00 AM - Mar 31, 2023 4:15 PM

(US Eastern Standard Time)

DIA/FDA Biostatistics Industry and Regulator Forum

Join us virtually from the comfort of your home/office March 29-31 or watch later at a time that works for you. This event provides access to the materials for a full two months!

Keynote: The Future of Evidence Generation: Planning for Novel Data Modalities

Session Chair(s)

Satrajit  Roychoudhury, PhD

Satrajit Roychoudhury, PhD

Executive Director, Statistical Research and Innovation

Pfizer, Inc., United States

Clinical research is changing as we move towards more advanced study designs and continuous evidence generation to better understand how treatments perform over time and to inform more personalized care. This involves collecting novel types of data to generate smarter evidence. It also involves close collaboration and creativity between disparate fields, including software design and data, privacy, clinical, and biostatistics. In this talk, Dr. Abernethy will speak about her experience at the FDA, the role of technology, regulation, policy, and types of analytic methods needed to power new approaches to data.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Recognize the changing environment of clinical research and evidence generation
  • Discuss approaches to collecting novel types of data for evidence generation
  • Explain analytic methods needed to power new approaches to data

Speaker(s)

Amy  Abernethy, MD, PhD

Speaker

Amy Abernethy, MD, PhD

Alphabet’s Verily, United States

President of Clinical Studies Platforms

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.